Grifols, S.A. (GIFLF)
| Previous Close | 13.07 |
| Open | 14.51 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 14.51 - 14.51 |
| 52 Week Range | 7.90 - 21.00 |
| Volume | |
| Avg. Volume | 2,486 |
| Market Cap | 8.8B |
| Beta (5Y Monthly) | 0.33 |
| PE Ratio (TTM) | 13.37 |
| EPS (TTM) | 1.09 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jun 03, 2021 |
| 1y Target Est | N/A |
- Reuters
Grifols considers selling 2 bln euros worth of assets to cut debt, Cinco Dias says
Spanish pharmaceutical company Grifols considers selling assets worth about 2 billion euros ($2.12 billion) to cut its debt, Cinco Dias reported on Wednesday, citing unidentified financial sources. The company may sell its Chinese business and its diagnoses unit, Cinco Dias reported. A spokesperson for the company declined to comment though in November Grifols said it was committed to reducing its 9.4 billion net debt.
- Reuters
Spanish pharmaceuticals firm Grifols reports 30% drop in nine-month profit
Spanish pharmaceutical company Grifols reported a 30% drop in nine-month net profit on Tuesday, due in part to acquisition costs. Grifols said it was still on track to meet its full-year financial targets, but its shares fell 4.2% in morning trade. The company, which uses blood plasma to make medicines, saw its business severely hit by the pandemic as blood collection was halted in many countries.
- Reuters
Grifols says U.S. blood donors' lawsuit won't have material impact, shares down
Spanish pharma group Grifols said on Friday a lawsuit filed in the United States by blood donors who claim the company violated their privacy would have no material impact, after a report in newspaper El Economista sent the shares sharply lower. The company said about 54,000 donors in Illinois had filed a lawsuit claiming Grifols breached data protection regulations, confirming the newspaper report. Grifols shares were down 5.3% on Friday morning, briefly the worst performer on the blue-chip Ibex-35 index, which was down 2.1%.
